Syndax Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good afternoon and welcome to the Morgan Stanley 18th Annual Global Healthcare Conference. I'm one of the biotech analysts here. My name is David Lebowitz. And before I get going, I have to go through the requisite disclosures. Please note that this webcast is for Morgan Stanley clients and appropriate Morgan Stanley employees only. Webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
And with that, I'd like to introduce. From Syndax Pharmaceuticals, I have CEO, Briggs Morrison; President and Chief Operating Officer, Michael Metzger; and CFO, Daphne Karydas.
And I guess before we really dig in here, if you could kind of give a top-level description of the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |